Yuxi has been with Eli Lilly since 2022, first serving as Senior Director for Eli Lilly’s venture arm, and recently transitioning to Business Development Strategy & Growth. Before joining Eli Lilly, she spent 2 years at Autobahn Labs. She also spent over 2 years at University of California, San Francisco as an Alliance and Business Development Manager. Yuxi’s scientific background is in metabolism, spanning adipose cell biology, insulin resistance, and immune regulation. She received her PhD at Columbia University followed by postdoctoral training at University of California, San Francisco.